World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Ruiz-Malagón AJ, Herraiz-Vilela M, Serrano-Pino R, García-Ávila P, Díaz-Suárez L, Carmona-Segovia AD, Becerra-Munoz VM, Jiménez-Navarro M, Arranz-Salas I, López-Villodres JA, Fernández-Castañer A, Gutiérrez-Martínez F, Rodríguez-González FJ, Camargo-Camero R, Alcaín-Martínez G, Rodríguez-Díaz C, García-Fuentes E, Sánchez-Quintero MJ, López-Gómez C. Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease. World J Gastroenterol 2025; 31(41): 110955 [PMID: 41257277 DOI: 10.3748/wjg.v31.i41.110955]
URL:	https://www.wjgnet.com/1007-9327/full/v31/i41/110955.htm

For:

Ruiz-Malagón AJ, Herraiz-Vilela M, Serrano-Pino R, García-Ávila P, Díaz-Suárez L, Carmona-Segovia AD, Becerra-Munoz VM, Jiménez-Navarro M, Arranz-Salas I, López-Villodres JA, Fernández-Castañer A, Gutiérrez-Martínez F, Rodríguez-González FJ, Camargo-Camero R, Alcaín-Martínez G, Rodríguez-Díaz C, García-Fuentes E, Sánchez-Quintero MJ, López-Gómez C. Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease. World J Gastroenterol 2025; 31(41): 110955 [PMID: 41257277 DOI: 10.3748/wjg.v31.i41.110955]

URL:

https://www.wjgnet.com/1007-9327/full/v31/i41/110955.htm

(57) (95) (0) (0) (0) (13) (1) (1) (1111) (4)

Number	Citing Articles
1	Tao Nie, Hongmei Song, Xiaofang Shen, Liufeng Mao. GDF15 as a sentinel of metabolic integrity: a narrative review of stress signaling, multisystem pathophysiology, and therapeutic potential. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1885104
2	Jia Yang, Ya-Ting Pan, Hong-Zhu Wen. Growth differentiation factor 15 - a new molecular target in inflammatory bowel disease: Progress and challenges. World Journal of Gastroenterology 2026; 32(5): 115439 doi: 10.3748/wjg.v32.i5.115439 Abstract(115) \| Core Tip(101) \| Full Article(HTML)(509) \| Full Article (PDF)-1479K(265) \| Full Article with Cover (PDF)-2996K(245) \| Full Article (XML)-80K(53) \| Audio-2447K(7) \| Peer-Review Report-262K(56) \| Answering Reviewers-252K(77) \| Times Cited (0) \| Total Visits (1223) \| Open
3	Mohammad Samimi Tanoorjeh, Hossein Shahdadi Sardou, Sara Feizollahi, Prashant Kesharwani, Mohammadreza Abbaspour, Amirhossein Sahebkar. Targeting mitochondrial dysfunction through nanomedicine: a new avenue for inflammatory bowel disease therapy. Microchemical Journal 2026; 224 doi: 10.1016/j.microc.2026.117838
4	Enshuo Liu, Jianbo Jia, Qi Liu, Chunyan Li, Shanhui Li, Tao Cai. The Microbiome-Mitochondria Axis in aging: a self-reinforcing vicious cycle linking metabolic dysregulation, mitochondrial quality control failure, and inflammaging. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1874222
5	Irene Díaz-Alberola, Daniel E. Di Zeo-Sánchez, Vanesa Garrido-Rodríguez, Carlos López-Gómez, Cristina Rodríguez-Díaz, Raul J. Andrade, M. Isabel Lucena, Marina Villanueva-Paz, Eduardo García-Fuentes. The gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system. Acta Pharmaceutica Sinica B 2026; 16(7) doi: 10.1016/j.apsb.2026.04.014